These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 21473672)
1. Honokiol inhibits hypoxia-inducible factor-1 pathway. Lan KL; Lan KH; Sheu ML; Chen MY; Shih YS; Hsu FC; Wang HM; Liu RS; Yen SH Int J Radiat Biol; 2011 Jun; 87(6):579-90. PubMed ID: 21473672 [TBL] [Abstract][Full Text] [Related]
2. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
3. Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model. Vavilala DT; O'Bryhim BE; Ponnaluri VK; White RS; Radel J; Symons RC; Mukherji M Biochem Biophys Res Commun; 2013 Sep; 438(4):697-702. PubMed ID: 23921228 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases. Vavilala DT; Ponnaluri VK; Kanjilal D; Mukherji M PLoS One; 2014; 9(11):e113717. PubMed ID: 25422886 [TBL] [Abstract][Full Text] [Related]
5. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314 [TBL] [Abstract][Full Text] [Related]
6. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases. Vavilala DT; Ponnaluri VK; Vadlapatla RK; Pal D; Mitra AK; Mukherji M Biochem Biophys Res Commun; 2012 Jun; 422(3):369-74. PubMed ID: 22580280 [TBL] [Abstract][Full Text] [Related]
7. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model. Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905 [TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α. Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions. Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528 [TBL] [Abstract][Full Text] [Related]
10. Honokiol Attenuates Choroidal Neovascularization by Inhibiting the Hypoxia-Inducible Factor-α/Vascular Endothelial Growth Factor Axis via Nuclear Transcription Factor-Kappa B Activation. Pan N; Shi J; Du S; Qiu Z; Ran Q; Guo Y; Ma A; Zhang Q; Sang A; Yang X Curr Eye Res; 2024 Jan; 49(1):88-96. PubMed ID: 37707827 [TBL] [Abstract][Full Text] [Related]
11. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation. Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543 [TBL] [Abstract][Full Text] [Related]
12. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways. Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358 [TBL] [Abstract][Full Text] [Related]
13. Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Kim HH; Lee SE; Chung WJ; Choi Y; Kwack K; Kim SW; Kim MS; Park H; Lee ZH Cytokine; 2002 Jan; 17(1):14-27. PubMed ID: 11886167 [TBL] [Abstract][Full Text] [Related]
14. Honokiol: a potent chemotherapy candidate for human colorectal carcinoma. Chen F; Wang T; Wu YF; Gu Y; Xu XL; Zheng S; Hu X World J Gastroenterol; 2004 Dec; 10(23):3459-63. PubMed ID: 15526365 [TBL] [Abstract][Full Text] [Related]
16. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Hahm ER; Arlotti JA; Marynowski SW; Singh SV Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560 [TBL] [Abstract][Full Text] [Related]
17. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Cao Z; Fang J; Xia C; Shi X; Jiang BH Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429 [TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition. Choi H; Chun YS; Kim SW; Kim MS; Park JW Mol Pharmacol; 2006 Nov; 70(5):1664-71. PubMed ID: 16880289 [TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy. García-Maceira P; Mateo J Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810 [TBL] [Abstract][Full Text] [Related]
20. Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs. Prasad R; Katiyar SK Adv Exp Med Biol; 2016; 928():245-265. PubMed ID: 27671820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]